G. MAZZACCA, M.D.; A. D'ARIENZO, M.D.; G. AMBROGIO, M.D.
To the editor: Albibi and McCallum (1) recently reviewed the pharmacologic aspects and clinical applications of metoclopramide. They mentioned that the drug increases plasma aldosterone levels. We should like to point out that this effect also can be elicited in clinical conditions with secondary hyperaldosteronism, such as liver cirrhosis with ascites. In 15 patients with ascites due to cirrhosis of the liver and with high serum aldosterone levels (288 ± 74 pg/mL), we found that a parenteral bolus of 10 mg of metoclopramide caused a further statistically significant increase of the hormonal serum concentrations (354 ± 90 pg/mL; p <
Learn more about subscription options.
Register Now for a free account.
MAZZACCA G, D'ARIENZO A, AMBROGIO G. Metoclopramide and Secondary Hyperaldosteronism. Ann Intern Med. 1983;98:1024–1025. doi: 10.7326/0003-4819-98-6-1024_2
Download citation file:
Published: Ann Intern Med. 1983;98(6):1024-1025.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only